Boule Diagnostics AB (publ)
BOUL.ST
Price:
$5.38
Market Cap:
$208.92M
Boule Diagnostics AB (publ), a diagnostics company, develops, manufactures, and markets instruments and consumable products for blood diagnostics. The company provides hematology analyzers, reagents, blood controls and calibrators, and reagents rotors, as well as cleaning products under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer and diagnostics systems under the Exigo brand. It sells its products directly in Sweden and the United States, as well as through distributors internationally. The company serves hospitals, clinics, laboratories, healthcare centers and veterinary clinics, and other diagnostics companies. It has operations in Swe...[Read more]
Industry
Medical - Devices
IPO Date
2011-06-23
Stock Exchange
STO
Ticker
BOUL.ST
PE Ratio
[-2.57]
ROE
[-3.83%]
Current Ratio
[1.10]
Dividend Yield
[0%]
Enterprise Value
[393.72M]
Dividend History
The ROE as of December 2025 (TTM) for Boule Diagnostics AB (publ) (BOUL.ST) is -3.83%
According to Boule Diagnostics AB (publ)’s latest financial reports and current stock price. The company's current ROE is -3.83%. This represents a change of 296.25% compared to the average of -0.97% of the last 4 quarters.
Boule Diagnostics AB (publ) (BOUL.ST) Historical ROE (quarterly & annually)
How has BOUL.ST ROE performed in the past?
The mean historical ROE of Boule Diagnostics AB (publ) over the last ten years is -2.18%. The current -3.83% ROE has changed 75.84% with respect to the historical average. Over the past ten years (40 quarters), BOUL.ST's ROE was at its highest in in the September 2017 quarter at 8.74%. The ROE was at its lowest in in the September 2024 quarter at -89.92%.
Average
-2.18%
Median
8.01%
Minimum
-82.83%
Maximum
15.68%
Boule Diagnostics AB (publ) (BOUL.ST) ROE by Quarter and Year
Discovering the peaks and valleys of Boule Diagnostics AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 92.57%
Maximum Annual ROE = 15.68%
Minimum Annual Increase = -1675.47%
Minimum Annual ROE = -82.83%
| Year | ROE | Change |
|---|---|---|
| 2024 | -82.83% | -1675.47% |
| 2023 | 5.26% | 91.04% |
| 2022 | 2.75% | -65.03% |
| 2021 | 7.87% | -144.18% |
| 2020 | -17.81% | -257.90% |
| 2019 | 11.28% | -17.29% |
| 2018 | 13.64% | -4.13% |
| 2017 | 14.23% | -9.29% |
| 2016 | 15.68% | 92.57% |
| 2015 | 8.14% | -54.26% |
Boule Diagnostics AB (publ) (BOUL.ST) Average ROE
How has BOUL.ST ROE performed in the past?
The current ROE of Boule Diagnostics AB (publ) (BOUL.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-24.94%
5-year avg
-16.95%
10-year avg
-2.18%
Boule Diagnostics AB (publ) (BOUL.ST) ROE vs. Peers
How is BOUL.ST’s ROE compared to its peers?
Boule Diagnostics AB (publ)’s ROE is greater than Mentice AB (publ) (-36.09%), greater than Physitrack PLC (-34.85%), greater than Promimic AB (publ) (-18.79%), greater than Clinical Laserthermia Systems AB (publ) (-57.03%), greater than Karolinska Development AB (publ) (-11.56%), greater than AlzeCure Pharma AB (publ) (-157.97%), greater than Acarix AB (publ) (-94.56%), greater than Integrum AB (publ) (-17.96%), greater than BrainCool AB (publ) (-27.96%), greater than IRLAB Therapeutics AB (publ) (-576.33%),
| Company | ROE | Market cap |
|---|---|---|
| -36.09% | $346.65M | |
| -34.85% | $211.39M | |
| -18.79% | $268.27M | |
| -57.03% | $182.21M | |
| -11.56% | $120.68M | |
| -157.97% | $243.62M | |
| -94.56% | $310.63M | |
| -17.96% | $223.41M | |
| -27.96% | $147.36M | |
| -576.33% | $162.59M |
Build a custom stock screener for Boule Diagnostics AB (publ) (BOUL.ST) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Boule Diagnostics AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Boule Diagnostics AB (publ) (BOUL.ST) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Boule Diagnostics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Boule Diagnostics AB (publ)'s ROE?
How is the ROE calculated for Boule Diagnostics AB (publ) (BOUL.ST)?
What is the highest ROE for Boule Diagnostics AB (publ) (BOUL.ST)?
What is the 3-year average ROE for Boule Diagnostics AB (publ) (BOUL.ST)?
What is the 5-year average ROE for Boule Diagnostics AB (publ) (BOUL.ST)?
How does the current ROE for Boule Diagnostics AB (publ) (BOUL.ST) compare to its historical average?